Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Drug Manufacturers - Specialty & Generic
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:RVV)

Fundamentals Snapshot (CSE:RVV)

Current News (CSE:RVV)

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire 10 days ago

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire May 12, 2023

Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase 3 Clinical Study of Bucillamine in the Treatment of COVID-19

GlobeNewswire May 2, 2023

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire April 18, 2023

Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

GlobeNewswire April 3, 2023

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

GlobeNewswire March 28, 2023

Revive Therapeutics (CSE:RVV) updates on Phase 3 clinical study for Bucillamine

Research March 20, 2023

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire March 20, 2023

Revive Therapeutics (CSE:RVV) revising Bucillamine study endpoints

Caroline Egan  March 8, 2023
View More News ››

Opinion & Analysis (CSE:RVV)

A Potential Psychedelic and COVID Therapy Play…All in One Stock

Dave Jackson June 18, 2020

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Streetwise Reports June 4, 2020
View More Opinion ››

Bullboard Posts (CSE:RVV)

$RVV Update

https://ca.finance.yahoo.com/news/revive-therapeutics-provides-phase-3-113000619.html
cool888 - 10 days ago

Pfizer's COVID antiviral Paxlovid gains full US approval

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-covid-antiviral-pill-2023-05-25/  
cool888 - May 25, 2023

China braces for new Covid wave ! 65 million weekly !!

#Bucillamine https://www.cnbctv18.com/world/china-braces-for-new-covid-19-wave-with-up-to-65-million-weekly-cases-16728131.htm...
cool888 - May 23, 2023

$RVVTF - fyi ... (NR tomorrow?)

#Bucillamine https://www.stockwatch.com/Quote/Detail?U:RVVTF  
cool888 - May 22, 2023

Bird flu reported in Chinese boy – first human case of H3N8

https://en.mercopress.com/2022/04/27/bird-flu-reported-in-chinese-boy-first-human-case-of-h3n8
opsd1 - May 22, 2023

Two U.K. poultry workers test positive for bird flu

https://www.upi.com/Top_News/World-News/2023/05/16/UK-Bird-Flu-poultry/1861684262721/
opsd1 - May 16, 2023
View more Bullboard ››

HAVN Life Sciences

HAVN Life Sciences

HAVN Life Sciences Inc is a biotechnology company engaged in the business of the research and development of psycho ...
View More »